pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: pdufa×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07477054: A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System

    Sponsor: Lungpacer Medical Inc.. Phase: NA. Conditions: Ventilator Induced Diaphragm Dysfunction

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01711554: Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Recurrent Neuroblastoma, Refractory Neuroblastoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06269666: P200TxE Diseased Eye Image Collection

    Sponsor: Optos, PLC. Phase: NA. Conditions: Retinal Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06191666: BfedBwell Proof-of-Concept Pilot

    Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Cancer Survivorship, Obesity, Overweight

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07626164: Three Photobiomodulation Wavelengths (635, 940, and 1064 nm) on Chronic Myogenic Temporomandibular Disorder

    Sponsor: Alexandria University. Phase: NA. Conditions: Temporomandibular Disorders

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT06103734: A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants

    Sponsor: Pfizer. Phase: PHASE3. Conditions: Migraine

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06768034: SecondarY Prevention and maNagement of Myocardial Injury aftER Noncardiac surGerY (SYNERGY) Pilot Trial

    Sponsor: Centre hospitalier de l'Université de Montréal (CHUM). Phase: NA. Conditions: Myocardial Injury After Noncardiac Surgery (MINS)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06055309: Behavioral Pharmacology of Cannabis in Older Adults

    Sponsor: University of Arkansas. Phase: PHASE1. Conditions: Health Services for the Aged

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05367609: Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)

    Sponsor: Senthil Sadhasivam. Phase: NA. Conditions: PPAP, Spine Fusion

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04418999: Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus

    Sponsor: Illinois College of Optometry. Phase: EARLY_PHASE1. Conditions: Keratoconus, Dry Eye, Allergy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07281599: Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

    Sponsor: Qurasense. Phase: NA. Conditions: HPV Infection, HPV 16 Infection, High Risk HPV, Cervical Cancer Screening, Cervical Cancer Cin Grade, Cervical Cancer (Early Detection), HPV, HPV (Human Papillomavirus)-Associated, HPV DNA, HPV Infections, Screening Test

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04290663: Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

    Sponsor: Centre Francois Baclesse. Phase: PHASE3. Conditions: Thyroid Cancer, Intermediate Risk

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07627893: Complementary Herbal Approach to Rheumatoid Management Study (CHARMS)

    Sponsor: Singapore General Hospital. Phase: PHASE2. Conditions: Rheumatoid Arthritis (RA)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06812793: Muscle Endurance in Children With Cystic Fibrosis

    Sponsor: Bezmialem Vakif University. Phase: . Conditions: Cystic Fibrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05321121: Dexmedotomidine for Acute Pain Control in Patients With Multiple Rib FracturesRandomized Controlled Trial

    Sponsor: University of California, Irvine. Phase: PHASE4. Conditions: Rib Fractures, Pain, Acute

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05911321: Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: PHASE2. Conditions: Multiple Myeloma, Relapse, Refractory, Aging, Co-morbidity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05946993: Linking In With Advice and Supports for Men Impacted by Metastatic Cancer

    Sponsor: University College Cork. Phase: NA. Conditions: Survivorship, Prostate Cancer, Kidney Cancer, Urothelial Tract/Bladder Cancer, Nos, Testicular Cancer, Penile Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02061306: Celiac Disease Genomic Environmental Microbiome and Metabolomic Study

    Sponsor: Massachusetts General Hospital. Phase: . Conditions: Celiac Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06492304: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

    Sponsor: CRISPR Therapeutics. Phase: PHASE1. Conditions: T Cell Lymphoma, B Cell Lymphoma, Acute Myeloid Leukemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07471204: Evaluation of Muscle Oxygenation and Recovery Dynamics in Individuals With Knee Osteoarthritis

    Sponsor: Bahçeşehir University. Phase: . Conditions: Osteoarthritis of Knee, Healthy Participants

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03854552: A Study in Healthy Men Tests How Different Doses of BI 764198 Are Taken up in the Body and How Well They Are Tolerated.

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07410949: Postpartum Acupressure Education and Breastfeeding Outcomes

    Sponsor: Nigde Omer Halisdemir University. Phase: NA. Conditions: Breastfeeding, Lactation, Postpartum Period

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06463158: The Impact of the Family Room App on Caregivers

    Sponsor: University of Nebraska. Phase: NA. Conditions: Well-Being, Psychological, Engagement, Satisfaction, Consumer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07468955: Impact of Cardiac Rehabilitation on Patient Outcomes

    Sponsor: Kutahya Health Sciences University. Phase: NA. Conditions: Coronary Artery Disease, Coronary Heart Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00605878: Studies of Skin Microbes in Healthy People and in People With Skin Conditions

    Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Eczema, Atopic Dermatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06927115: Comparative Analysis of Mulligan and Maitland Mobilizations Techniques in Adhesive Capsulitis

    Sponsor: Riphah International University. Phase: NA. Conditions: Adhesive Capsulitis of Shoulder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04391335: Novel Pulmonary Function Measures for Diagnosis of Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem-Cell Transplantation in Children

    Sponsor: The Hospital for Sick Children. Phase: . Conditions: Bronchiolitis Obliterans Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00083135: N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation

    Sponsor: New Approaches to Neuroblastoma Therapy Consortium. Phase: PHASE1. Conditions: Neuroblastoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02710435: REDUCER-I: An Observational Study of the Neovasc Reducer™ System

    Sponsor: Shockwave Medical, Inc.. Phase: . Conditions: Angina Pectoris, Angina Pectoris, Stable, Chronic Stable Angina

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06784908: Stress and Pain in People Living With HIV

    Sponsor: Yale University. Phase: NA. Conditions: HIV, Depression, Cannabis Use Disorder, Stress, Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07263776: Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2

    Sponsor: Capital Medical University. Phase: PHASE3. Conditions: Acute Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07398417: Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

    Sponsor: Axsome Therapeutics, Inc.. Phase: PHASE3. Conditions: Fibromyalgia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05520840: Evaluation of Peripheral Blood Protein Biomarkers for Colorectal Cancer Screening

    Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05508789: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07404293: Zero CDE Technique for Lens Removal During FLACS

    Sponsor: Bochner Eye Institute. Phase: NA. Conditions: Cataract With a Nuclear Sclerosis Grade Between 1 to 3

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07359521: Implementation and Evaluation of a Complex Intervention to Reduce Avoidable Transitions Between Nursing Home and Hospital

    Sponsor: Vrije Universiteit Brussel. Phase: NA. Conditions: Potentially Avoidable Hospitalisations

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05097521: Assessing Pain, Patient Reported Outcomes and Complementary and Integrative Health

    Sponsor: VA Office of Research and Development. Phase: . Conditions: Chronic Musculoskeletal Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05723614: TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven

    Sponsor: Yale University. Phase: NA. Conditions: Firearm Injury

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04298606: A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

    Sponsor: Roswell Park Cancer Institute. Phase: EARLY_PHASE1. Conditions: Chronic Obstructive Pulmonary Disease, Lung Non-Small Cell Carcinoma, Pneumonia, Stage IB Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04984733: Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer

    Sponsor: University of Southampton. Phase: PHASE2. Conditions: Adenocarcinoma - GEJ, Cancer of Esophagus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07582952: Effect of Meal Frequency on Diet Self-Efficacy and Perceived Stress in Women With Weight Cycling

    Sponsor: Ankara Medipol University. Phase: NA. Conditions: Weight Cycling, Obesity & Overweight, Dietary Self-efficiacy, Perceived Stress, Meal Frequency

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07568847: Improving Hospital-To-Methadone Clinic Connection Using Implementation Support for Patients With Opioid Use Disorder

    Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Opioid Use Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07616349: Prediction of Platelet Function Using Viscoelastic Test (ROTEM® Sigma) in Obstetric Anesthesia.

    Sponsor: Nicolas Brogly. Phase: . Conditions: Thrombocytopenia, Postpartum Haemorrhage (PPH)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07321249: Is There an Association Between Smartsphone Addiction and Obesity in Young Adults?

    Sponsor: Alaa Mohamed Naguib Ashry. Phase: . Conditions: Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07631338: Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic Strategies

    Sponsor: Hospital Italiano de Buenos Aires. Phase: . Conditions: Low-grade Glioma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06657248: Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant

    Sponsor: Aesculap AG. Phase: . Conditions: Gonarthritis, Degenerative Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05875155: Ovarian Tissue Cryopreservation for Fertility Preservation

    Sponsor: University of Pittsburgh. Phase: . Conditions: Cancer, Autoimmune Diseases

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06416878: Brief ES for Recovery of Autonomic Function in CES

    Sponsor: University of Liverpool. Phase: NA. Conditions: Cauda Equina Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07574385: Sciatic Nerve Block With ALX006 in Subjects Undergoing Bunionectomy

    Sponsor: Rebel Medicine Inc. Phase: PHASE2. Conditions: Hallux Valgus, Bunionectomy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07462585: Impact of the Model Health Behaviour Mother 1000 Days of Life Health Online-Based on Prenatal, Intranatal, and Postnatal

    Sponsor: Siti Saidah Nasution. Phase: NA. Conditions: Pregnancy

    full page →ctgov ↗
    ← prev
    page 78 of 104
    next →